There are still numerous unidentified target mRNAs for IGF2BP1—including ACTB, CTNNB1, GLI1, IGF2, MAPK4, MDR1, PPP1R9B, CD44, MYC, PTEN, and BTRC which indicate that this protein modulates multiple important aspects of cellular function during both normal development and cancer (Bell et al., 2013). Here, IGF2BP1 is linked to cancer.